HK Stock MarketDetailed Quotes

01875 TOT BIOPHARM-B

Watchlist
  • 1.600
  • -0.020-1.23%
Market Closed Dec 20 16:08 CST
1.24BMarket Cap37.21P/E (TTM)

TOT BIOPHARM-B Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q6)Jun 30, 2024
(FY)Dec 31, 2023
(Q6)Jun 30, 2023
(FY)Dec 31, 2022
(Q6)Jun 30, 2022
(FY)Dec 31, 2021
(Q6)Jun 30, 2021
(FY)Dec 31, 2020
(Q6)Jun 30, 2020
(FY)Dec 31, 2019
Cash flow from operating activities
Earning before tax
----
24.56%-37.76M
----
80.84%-50.05M
----
9.46%-261.22M
----
3.61%-288.5M
----
-11.57%-299.3M
Profit adjustment
Interest (income) - adjustment
----
-31.30%-2.97M
----
-133.75%-2.27M
----
48.46%-969K
----
-11.90%-1.88M
----
-131.09%-1.68M
Interest expense - adjustment
----
-21.61%5.18M
----
167.50%6.6M
----
44.67%2.47M
----
-25.53%1.71M
----
-4.70%2.29M
Attributable subsidiary (profit) loss
----
-62.39%2.5M
----
38,917.65%6.63M
----
--17K
----
----
----
----
Impairment and provisions:
----
3,021.44%18.64M
----
--597K
----
----
----
----
----
----
-Impairment of property, plant and equipment (reversal)
----
--7.15M
----
----
----
----
----
----
----
----
-Other impairments and provisions
----
1,823.12%11.48M
----
--597K
----
----
----
----
----
----
Revaluation surplus:
----
-2.74%-937K
----
---912K
----
----
----
-107.88%-2.21M
----
-2.51%28.06M
-Other fair value changes
----
-2.74%-937K
----
---912K
----
----
----
-107.88%-2.21M
----
-2.51%28.06M
Asset sale loss (gain):
----
44.98%3.42M
----
-52.85%2.36M
----
968.58%5M
----
-225.49%-576K
----
9,080.00%459K
-Loss (gain) on sale of property, machinery and equipment
----
44.98%3.42M
----
-57.01%2.36M
----
2,582.81%5.49M
----
-148.15%-221K
----
9,080.00%459K
-Loss (gain) from selling other assets
----
----
----
----
----
-36.34%-484K
----
---355K
----
----
Depreciation and amortization:
----
13.12%43.03M
----
11.10%38.04M
----
6.72%34.24M
----
17.30%32.08M
----
74.70%27.35M
-Depreciation
----
13.12%43.03M
----
11.10%38.04M
----
6.72%34.24M
----
17.30%32.08M
----
74.70%27.35M
Special items
----
-33.94%10.64M
----
204.21%16.11M
----
-66.55%5.3M
----
-35.41%15.83M
----
-4.54%24.51M
Operating profit before the change of operating capital
----
143.77%41.73M
----
107.96%17.12M
----
11.65%-215.16M
----
-11.56%-243.54M
----
-11.12%-218.31M
Change of operating capital
Inventory (increase) decrease
----
52.21%-31.19M
----
-204.34%-65.26M
----
-400.50%-21.44M
----
158.76%7.14M
----
-471.53%-12.15M
Accounts receivable (increase)decrease
----
5.51%-36.81M
----
-324.27%-38.95M
----
-207.32%-9.18M
----
281.56%8.56M
----
-47.53%-4.71M
Accounts payable increase (decrease)
----
33.38%111.74M
----
-17.18%83.77M
----
450.15%101.15M
----
-699.32%-28.89M
----
-86.55%4.82M
prepayments (increase)decrease
----
-64.65%22.6M
----
290.83%63.95M
----
-130.78%-33.51M
----
26.06%-14.52M
----
-62.13%-19.64M
Special items for working capital changes
----
-1,744.51%-54.62M
----
-244.79%-2.96M
----
-74.62%2.05M
----
1,084.00%8.06M
----
-127.66%-819K
Cash  from business operations
-58.09%25.62M
-7.29%53.46M
114.98%61.14M
132.74%57.66M
130.16%28.44M
33.09%-176.11M
11.31%-94.29M
-4.94%-263.2M
15.19%-106.31M
-43.23%-250.81M
Other taxs
----
---1K
----
----
----
----
----
----
----
----
Interest received - operating
70.74%2.18M
31.30%2.97M
207.95%1.28M
133.75%2.27M
-41.88%415K
-48.46%969K
2.29%714K
11.90%1.88M
-56.32%698K
131.09%1.68M
Interest paid - operating
----
----
----
----
----
----
96.55%-46K
18.60%-1.79M
-520.47%-1.33M
10.11%-2.2M
Net cash from operations
-55.46%27.8M
-5.84%56.43M
116.32%62.41M
134.22%59.93M
130.82%28.85M
33.44%-175.14M
12.46%-93.62M
-4.69%-263.12M
13.73%-106.95M
-42.13%-251.33M
Cash flow from investment activities
Sale of fixed assets
--69K
-74.40%480K
----
10,316.67%1.88M
14.29%16K
-94.97%18K
180.00%14K
1,784.21%358K
--5K
--19K
Purchase of fixed assets
----
17.45%-197.28M
----
-112.84%-238.98M
----
-448.07%-112.28M
----
43.54%-20.49M
----
52.66%-36.29M
Purchase of intangible assets
----
-417.85%-5.92M
53.83%-187K
62.28%-1.14M
-5.47%-405K
-78.87%-3.03M
54.01%-384K
-60.72%-1.69M
-292.02%-835K
32.09%-1.05M
Sale of subsidiaries
----
--3M
--3M
----
----
----
----
----
----
----
Recovery of cash from investments
----
48.96%321.22M
--321.22M
2,466.46%215.63M
----
-97.90%8.4M
----
238.86%399.92M
2,020.37%135.22M
-20.06%118.02M
Cash on investment
83.16%-68.85M
-9.78%-285.6M
-548.62%-408.78M
-17,243.33%-260.15M
-14.29%-63.02M
99.59%-1.5M
85.10%-55.14M
-177.37%-365.57M
-988.40%-370.18M
-13.13%-131.8M
Net cash from investment operations
18.84%-68.78M
41.96%-164.11M
-33.65%-84.75M
-160.87%-282.76M
-14.23%-63.41M
-965.34%-108.39M
76.46%-55.51M
124.51%12.53M
-746.74%-235.79M
-8.57%-51.1M
Net cash before financing
-83.49%-40.98M
51.68%-107.67M
35.37%-22.34M
21.41%-222.84M
76.83%-34.56M
-13.14%-283.53M
56.49%-149.13M
17.14%-250.59M
-125.76%-342.74M
-35.07%-302.43M
Cash flow from financing activities
New borrowing
-3.89%111.82M
-52.44%132.15M
16.35%116.35M
34.90%277.86M
38.55%100M
--205.97M
--72.18M
----
----
55.07%60M
Refund
3.18%-73.1M
61.52%-75.5M
-23.38%-75.5M
---196.19M
---61.19M
----
----
-11,900.00%-60M
-11,900.00%-60M
99.27%-500K
Issuing shares
----
----
----
----
----
--1.99M
--1.99M
----
----
10.76%541.95M
Interest paid - financing
29.95%-1.53M
-97.48%-12.61M
52.64%-2.18M
-219.35%-6.39M
---4.61M
---2M
----
----
----
----
Absorb investment income
----
----
----
--409.16M
----
----
----
----
----
----
Issuance expenses and redemption of securities expenses
----
----
----
---1.2M
----
----
----
----
-294.78%-18.22M
-1,065.08%-16.85M
Other items of the financing business
----
---3.38M
---3.38M
----
----
--7.62M
--7.62M
----
----
----
Net cash from financing operations
6.23%36.21M
-92.06%38.23M
2.10%34.09M
126.91%481.24M
-58.75%33.38M
443.69%212.08M
201.94%80.94M
-110.58%-61.71M
-247.55%-79.4M
27.41%583.02M
Effect of rate
-55.90%1.52M
-49.99%3.28M
6.44%3.46M
612.42%6.56M
397.07%3.25M
5.19%-1.28M
69.06%-1.09M
-173.45%-1.35M
-118.76%-3.53M
219.97%1.84M
Net Cash
-140.63%-4.77M
-126.88%-69.45M
1,099.15%11.75M
461.67%258.41M
98.28%-1.18M
77.12%-71.45M
83.84%-68.2M
-211.30%-312.3M
-330.74%-422.14M
20.06%280.59M
Begining period cash
-15.84%351.6M
173.40%417.77M
173.40%417.77M
-32.25%152.81M
-32.25%152.81M
-58.17%225.53M
-58.17%225.53M
110.00%539.18M
110.00%539.18M
944.51%256.75M
Cash at the end
-19.55%348.35M
-15.84%351.6M
179.56%432.98M
173.40%417.77M
-0.87%154.88M
-32.25%152.81M
37.65%156.24M
-58.17%225.53M
-27.76%113.51M
110.00%539.18M
Cash balance analysis
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
Audit Opinions
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
Auditor
--
PricewaterhouseCoopers
--
PricewaterhouseCoopers
--
PricewaterhouseCoopers
--
PricewaterhouseCoopers
--
PricewaterhouseCoopers
(Q6)Jun 30, 2024(FY)Dec 31, 2023(Q6)Jun 30, 2023(FY)Dec 31, 2022(Q6)Jun 30, 2022(FY)Dec 31, 2021(Q6)Jun 30, 2021(FY)Dec 31, 2020(Q6)Jun 30, 2020(FY)Dec 31, 2019
Cash flow from operating activities
Earning before tax ----24.56%-37.76M----80.84%-50.05M----9.46%-261.22M----3.61%-288.5M-----11.57%-299.3M
Profit adjustment
Interest (income) - adjustment -----31.30%-2.97M-----133.75%-2.27M----48.46%-969K-----11.90%-1.88M-----131.09%-1.68M
Interest expense - adjustment -----21.61%5.18M----167.50%6.6M----44.67%2.47M-----25.53%1.71M-----4.70%2.29M
Attributable subsidiary (profit) loss -----62.39%2.5M----38,917.65%6.63M------17K----------------
Impairment and provisions: ----3,021.44%18.64M------597K------------------------
-Impairment of property, plant and equipment (reversal) ------7.15M--------------------------------
-Other impairments and provisions ----1,823.12%11.48M------597K------------------------
Revaluation surplus: -----2.74%-937K-------912K-------------107.88%-2.21M-----2.51%28.06M
-Other fair value changes -----2.74%-937K-------912K-------------107.88%-2.21M-----2.51%28.06M
Asset sale loss (gain): ----44.98%3.42M-----52.85%2.36M----968.58%5M-----225.49%-576K----9,080.00%459K
-Loss (gain) on sale of property, machinery and equipment ----44.98%3.42M-----57.01%2.36M----2,582.81%5.49M-----148.15%-221K----9,080.00%459K
-Loss (gain) from selling other assets ---------------------36.34%-484K-------355K--------
Depreciation and amortization: ----13.12%43.03M----11.10%38.04M----6.72%34.24M----17.30%32.08M----74.70%27.35M
-Depreciation ----13.12%43.03M----11.10%38.04M----6.72%34.24M----17.30%32.08M----74.70%27.35M
Special items -----33.94%10.64M----204.21%16.11M-----66.55%5.3M-----35.41%15.83M-----4.54%24.51M
Operating profit before the change of operating capital ----143.77%41.73M----107.96%17.12M----11.65%-215.16M-----11.56%-243.54M-----11.12%-218.31M
Change of operating capital
Inventory (increase) decrease ----52.21%-31.19M-----204.34%-65.26M-----400.50%-21.44M----158.76%7.14M-----471.53%-12.15M
Accounts receivable (increase)decrease ----5.51%-36.81M-----324.27%-38.95M-----207.32%-9.18M----281.56%8.56M-----47.53%-4.71M
Accounts payable increase (decrease) ----33.38%111.74M-----17.18%83.77M----450.15%101.15M-----699.32%-28.89M-----86.55%4.82M
prepayments (increase)decrease -----64.65%22.6M----290.83%63.95M-----130.78%-33.51M----26.06%-14.52M-----62.13%-19.64M
Special items for working capital changes -----1,744.51%-54.62M-----244.79%-2.96M-----74.62%2.05M----1,084.00%8.06M-----127.66%-819K
Cash  from business operations -58.09%25.62M-7.29%53.46M114.98%61.14M132.74%57.66M130.16%28.44M33.09%-176.11M11.31%-94.29M-4.94%-263.2M15.19%-106.31M-43.23%-250.81M
Other taxs -------1K--------------------------------
Interest received - operating 70.74%2.18M31.30%2.97M207.95%1.28M133.75%2.27M-41.88%415K-48.46%969K2.29%714K11.90%1.88M-56.32%698K131.09%1.68M
Interest paid - operating ------------------------96.55%-46K18.60%-1.79M-520.47%-1.33M10.11%-2.2M
Net cash from operations -55.46%27.8M-5.84%56.43M116.32%62.41M134.22%59.93M130.82%28.85M33.44%-175.14M12.46%-93.62M-4.69%-263.12M13.73%-106.95M-42.13%-251.33M
Cash flow from investment activities
Sale of fixed assets --69K-74.40%480K----10,316.67%1.88M14.29%16K-94.97%18K180.00%14K1,784.21%358K--5K--19K
Purchase of fixed assets ----17.45%-197.28M-----112.84%-238.98M-----448.07%-112.28M----43.54%-20.49M----52.66%-36.29M
Purchase of intangible assets -----417.85%-5.92M53.83%-187K62.28%-1.14M-5.47%-405K-78.87%-3.03M54.01%-384K-60.72%-1.69M-292.02%-835K32.09%-1.05M
Sale of subsidiaries ------3M--3M----------------------------
Recovery of cash from investments ----48.96%321.22M--321.22M2,466.46%215.63M-----97.90%8.4M----238.86%399.92M2,020.37%135.22M-20.06%118.02M
Cash on investment 83.16%-68.85M-9.78%-285.6M-548.62%-408.78M-17,243.33%-260.15M-14.29%-63.02M99.59%-1.5M85.10%-55.14M-177.37%-365.57M-988.40%-370.18M-13.13%-131.8M
Net cash from investment operations 18.84%-68.78M41.96%-164.11M-33.65%-84.75M-160.87%-282.76M-14.23%-63.41M-965.34%-108.39M76.46%-55.51M124.51%12.53M-746.74%-235.79M-8.57%-51.1M
Net cash before financing -83.49%-40.98M51.68%-107.67M35.37%-22.34M21.41%-222.84M76.83%-34.56M-13.14%-283.53M56.49%-149.13M17.14%-250.59M-125.76%-342.74M-35.07%-302.43M
Cash flow from financing activities
New borrowing -3.89%111.82M-52.44%132.15M16.35%116.35M34.90%277.86M38.55%100M--205.97M--72.18M--------55.07%60M
Refund 3.18%-73.1M61.52%-75.5M-23.38%-75.5M---196.19M---61.19M---------11,900.00%-60M-11,900.00%-60M99.27%-500K
Issuing shares ----------------------1.99M--1.99M--------10.76%541.95M
Interest paid - financing 29.95%-1.53M-97.48%-12.61M52.64%-2.18M-219.35%-6.39M---4.61M---2M----------------
Absorb investment income --------------409.16M------------------------
Issuance expenses and redemption of securities expenses ---------------1.2M-----------------294.78%-18.22M-1,065.08%-16.85M
Other items of the financing business -------3.38M---3.38M----------7.62M--7.62M------------
Net cash from financing operations 6.23%36.21M-92.06%38.23M2.10%34.09M126.91%481.24M-58.75%33.38M443.69%212.08M201.94%80.94M-110.58%-61.71M-247.55%-79.4M27.41%583.02M
Effect of rate -55.90%1.52M-49.99%3.28M6.44%3.46M612.42%6.56M397.07%3.25M5.19%-1.28M69.06%-1.09M-173.45%-1.35M-118.76%-3.53M219.97%1.84M
Net Cash -140.63%-4.77M-126.88%-69.45M1,099.15%11.75M461.67%258.41M98.28%-1.18M77.12%-71.45M83.84%-68.2M-211.30%-312.3M-330.74%-422.14M20.06%280.59M
Begining period cash -15.84%351.6M173.40%417.77M173.40%417.77M-32.25%152.81M-32.25%152.81M-58.17%225.53M-58.17%225.53M110.00%539.18M110.00%539.18M944.51%256.75M
Cash at the end -19.55%348.35M-15.84%351.6M179.56%432.98M173.40%417.77M-0.87%154.88M-32.25%152.81M37.65%156.24M-58.17%225.53M-27.76%113.51M110.00%539.18M
Cash balance analysis
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards HKASHKASHKASHKASHKASHKASHKASHKASHKASHKAS
Audit Opinions --Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion
Auditor --PricewaterhouseCoopers--PricewaterhouseCoopers--PricewaterhouseCoopers--PricewaterhouseCoopers--PricewaterhouseCoopers

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
HK
Overall
Symbol
Price
% Chg

No Data

Investment Theme Pharmaceutical Companies
Pharmaceutical Companies
Intraday-0.05%